Bringing the fundamentals into focus…
Back to Immunome, Inc.
How Immunome, Inc. stacks up
IMNM · against 375 other Healthcare companies of similar size
Overall
27/ 100
Near the bottom of its peers.
Ranked #338 of 376 · scores higher than 9% of peers
Bars: peers in each 10-point band of the overall score36 peers with an overall score of 20–29, including IMNM · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around IMNM| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 335 | 3.7B USD | 28 | 8 | 6 | 4 | 0 / 2 | |
| 338 | 9.6B CNY (≈$1.3B) | 27 | 0 | 20 | 34 | 1 / 2 | |
| 338 | 3.1B USD | 27 | 8 | 12 | 3 | 0 / 2 | |
| 338 | 2.0B USD | 27 | 38 | 35 | 35 | 2 / 2 | |
| 338 | 2.4B USD | 27 | 8 | 8 | 3 | 0 / 2 | |
| 338 | 1.3B USD | 27 | 8 | 2 | 12 | 0 / 2 | |
| 338 | 2.3B USD | 27 | 8 | 15 | 14 | 0 / 2 | |
| 344 | 31.0B CNY (≈$4.3B) | 26 | 0 | 4 | 29 | 0 / 2 | |
| 344 | 1.5B USD | 26 | 8 | 62 | 16 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score